Login/Sign Up
Is it safe and clinically appropriate to discontinue diabetes medication, such as Istamet 50/500, for a patient with type 2 diabetes whose HbA1c has stabilized between 5.9% and 6.0% (estimated average glucose of 122?125 mg/dL), and what monitoring protocol should be followed after stopping treatment?
Is it safe and clinically appropriate to discontinue diabetes medication, such as Istamet 50/500, for a patient with type 2 diabetes whose HbA1c has stabilized between 5.9% and 6.0% (estimated average glucose of 122?125 mg/dL), and what monitoring protocol should be followed after stopping treatment?
Answered 18 days ago